Some market data could not be loaded. Please try again.
| Day | Period | ||
|---|---|---|---|
| Range: | Range: | ||
| Open: | Total Return: | ||
| Volume: | |||
| Day | Period | ||
|---|---|---|---|
| Range: | Range: | ||
| Open: | Total Return: | ||
| Volume: | |||
| Day | Period | ||
|---|---|---|---|
| Range: | Range: | ||
| Open: | Total Return: | ||
| Volume: | |||
| Day | Period | ||
|---|---|---|---|
| Range: | Range: | ||
| Open: | Total Return: | ||
| Volume: | |||
| Day | Period | ||
|---|---|---|---|
| Range: | Range: | ||
| Open: | Total Return: | ||
| Volume: | |||
Forex
| USD | CAD | EUR | GBP | INR | CNY | JPY | TWD | |
|---|---|---|---|---|---|---|---|---|
| USD | - | -- | -- | -- | -- | -- | -- | -- |
| CAD | -- | - | -- | -- | -- | -- | -- | -- |
| EUR | -- | -- | - | -- | -- | -- | -- | -- |
| GBP | -- | -- | -- | - | -- | -- | -- | -- |
| INR | -- | -- | -- | -- | - | -- | -- | -- |
| CNY | -- | -- | -- | -- | -- | - | -- | -- |
| JPY | -- | -- | -- | -- | -- | -- | - | -- |
| TWD | -- | -- | -- | -- | -- | -- | -- | - |
Yield Curve: US Treasuries
Daily Movers
| Ticker | Level |
|---|
Latest Reports
| Ticker | Title | Period | Published |
|---|---|---|---|
| IBN.US |
Core Operating Profit Expands 10.5% as Margin Compression Slows to 3 Basis Points
|
FY24
Q4
|
Oct 21 |
| IBN.US |
Net Profit Rises 23.6% as Margin Compression Moderates and Lending Filters Tighten
|
FY24
Q3
|
Oct 21 |
| IBN.US |
Net Profit Expands 35.8% on Lower Provisions as Deposit Repricing Compresses Margins
|
FY24
Q2
|
Oct 21 |
| MAN.US |
Organic Revenue Growth Sustained at 6% as Experis Inflects and Front-Office Transformation Expands
|
FY26
Q3
|
Oct 20 |
| LYV.US |
Ticketing Outlook Raised to Mid-Single-Digit Growth as Deferred Revenue Reaches $6.4 Billion
|
FY26
Q2
|
Oct 20 |
| IBN.US |
Core Operating Profit Rose 35.2% and Domestic Advances Expanded 20.6% Amid Sequential Margin Compression
|
FY24
Q1
|
Oct 20 |
| PCOR.US |
Operating Margin Expands 800 bps with First GAAP Operating Profit as FY 2026 Guidance Raised
|
FY26
Q2
|
Oct 20 |
| HDB.US |
Net Interest Margin Troughs at 3.32% as Commercial Advances Expand 28% Ahead of Rate Transmission
|
FY27
Q2
|
Oct 20 |
| HDB.US |
Commercial Credit Origination Accelerates as Offshore Deposit Mobilization Targets Margin Compression
|
FY27
Q1
|
Oct 20 |
| HDB.US |
Advances Growth Accelerates to 12% as Granular Liability Inflows Retire Loan-to-Deposit Constraints
|
FY26
Q4
|
Oct 20 |
| HDB.US |
Funding Costs Fall 10 to 11 Basis Points Sequentially as Distribution Strategy Pivots to Branch Maturation
|
FY26
Q3
|
Oct 20 |
| HDB.US |
Credit Expansion Accelerates as Margins Trough Ahead of Multi-Quarter Deposit Repricing
|
FY26
Q2
|
Oct 20 |
| HDB.US |
Advances Growth Accelerates to 8% as Credit-Deposit Ratio Contracts to 95%
|
FY26
Q1
|
Oct 20 |
| HDB.US |
Credit-Deposit Ratio Compresses to 96% and Core NIM Reaches 3.46% Ahead of Guided FY2026 Loan Acceleration
|
FY25
Q4
|
Oct 20 |
| HDB.US |
Loan-to-Deposit Ratio Contracts to 98% on 16% Deposit Accretion While Net Interest Margin Holds at 3.40%
|
FY25
Q3
|
Oct 20 |
| HDB.US |
Adjusted Profit Expands 17% as Deposit Accretion Accelerates Loan-to-Deposit Compression
|
FY25
Q2
|
Oct 20 |
| HDB.US |
Net Profit Rises 35.3% as Wholesale Borrowings Contract ₹62,816 Crore and Lending Moderates
|
FY25
Q1
|
Oct 20 |
| HDB.US |
Deposit Acceleration Compresses Credit-to-Deposit Ratio to 105% as Quantitative Guidance Is Discontinued
|
FY24
Q4
|
Oct 20 |
| HDB.US |
Credit-to-Deposit Ratio Rises to 111.5% as Systemic Liquidity Deficit Constrains Deposit Accretion
|
FY24
Q3
|
Oct 20 |
| HDB.US |
Deposit Accretion Rebounds to ₹1.1 Lakh Crore as Post-Merger Margins Absorb Temporary Liquidity Drag
|
FY24
Q2
|
Oct 20 |
| HDB.US |
Standalone Net Profit Rises 30% to ₹11,952 Crore as Housing Amalgamation Transfers ₹6.36 Lakh Crore in Liabilities
|
FY24
Q1
|
Oct 20 |
| HDB.US |
Net Profit Rises 19.8% on Record Deposit Mobilization as Accelerated Branch Rollout Elevates Cost-to-Income
|
FY23
Q4
|
Oct 19 |
| HDB.US |
Net Profit Expands 18.5% as Branch Accretion Accelerates and Core Margin Holds at 4.1%
|
FY23
Q3
|
Oct 19 |
| HDB.US |
Net Profit Rises 20.1% on 23.4% Credit Expansion as Amalgamation Timeline Advances to Early FY2024
|
FY23
Q2
|
Oct 19 |
| HDB.US |
Net Profit Expands 19% as Retail and Commercial Loan Growth Offsets Treasury Losses and Distribution Outlays
|
FY23
Q1
|
Oct 19 |
| HDB.US |
Net Profit Rises 22.8% on 20.8% Advance Growth as Asset Mix Shifts to Wholesale and Core NIM Moderates to 4.0%
|
FY22
Q4
|
Oct 19 |
| HDB.US |
Net Profit Rises 18.1% as Commercial Advances Expand 29.4% Amid Record Card Issuances
|
FY22
Q3
|
Oct 19 |
| HDB.US |
Advances Expand 15.5% as Credit Card Sourcing Resumes and Gross NPA Moderates to 1.35%
|
FY22
Q2
|
Oct 19 |
| HDB.US |
Net Revenues Expand 18.0% as Commercial Loan Growth Offsets Pandemic Retail Curbs Ahead of July Volume Rebound
|
FY22
Q1
|
Oct 19 |
| MWA.US |
Annual Adjusted EBITDA Guidance Raised as Adjusted EBITDA Margin Expands 440 bps to 27.1%
|
FY26
Q3
|
Oct 18 |
| MWA.US |
Adjusted EBITDA Outlook Raised on Manufacturing Efficiencies While Cash Conversion Target Lowered to 70%
|
FY26
Q2
|
Oct 18 |
| MWA.US |
Operating Margins Expand on Price Realization and Brass Efficiencies as Full-Year Outlook Increases
|
FY26
Q1
|
Oct 18 |
| MWA.US |
Gross Margin Expands 500 bps to 36.8% as Initial FY2026 Outlook Targets 100 bps EBITDA Margin Expansion
|
FY25
Q4
|
Oct 18 |
| MWA.US |
Gross Margin Expands to 38.3% as Full-Year Net Sales and Adjusted EBITDA Guidance Raised
|
FY25
Q3
|
Oct 18 |
| MWA.US |
Net Sales Guidance Raised to $1.39B–$1.40B as Targeted Pricing Offsets Newly Enacted Tariffs
|
FY25
Q2
|
Oct 18 |
| MWA.US |
Fiscal 2025 Outlook Raised Following 18.7% Net Sales Growth and Brass Foundry Decommissioning
|
FY25
Q1
|
Oct 18 |
| MWA.US |
Net Sales Rise 15.5% on Valve and Hydrant Volumes as Legacy Brass Foundry Closure Approaches
|
FY24
Q4
|
Oct 18 |
| MWA.US |
Water Flow Volume Drives 9.2% Net Sales Growth as Full-Year Adjusted EBITDA Outlook Raised to 34% to 36%
|
FY24
Q3
|
Oct 18 |
| MWA.US |
Gross Margin Expands 750 bps to 36.9% and FY24 Adjusted EBITDA Growth Guidance Raised to 23%–27%
|
FY24
Q2
|
Oct 18 |
| MWA.US |
Gross Margin Expands 410 Basis Points to 33.7% as Channel Destocking Concludes and EBITDA Outlook Introduced
|
FY24
Q1
|
Oct 18 |
| MWA.US |
Adjusted EBITDA Margin Expands to 18.4% on Realized Pricing; FY2024 Net Sales Guided Down 3% to 8% Amid Destocking
|
FY23
Q4
|
Oct 18 |
| MWA.US |
Full-Year Guidance Lowered on Extended Channel Destocking as Cost Actions Target $25M in Annual SG&A Savings
|
FY23
Q3
|
Oct 18 |
| MWA.US |
Hydrant Shipments Drive 7.2% Sales Growth Amid Gate Valve Destocking as Full-Year Cash Flow Guidance Is Revised
|
FY23
Q2
|
Oct 18 |
| MWA.US |
Net Sales Rise 15.6% on Price Realization While Foundry Inefficiencies Pressure Margins
|
FY23
Q1
|
Oct 18 |
| MWA.US |
Price Gains Lift Sales 12% as Foundry Downtime Pressures Margins Ahead of FY2023 Facility Commissioning
|
FY22
Q4
|
Oct 18 |
| MWA.US |
Net Sales Rise 7.3% on Pricing as Operational Bottlenecks Lower Full-Year EBITDA Guidance
|
FY22
Q3
|
Oct 18 |
| MWA.US |
Annual Sales Guidance Raised to 10%–12% on Price Realization While Foundry Downtime Tempers Conversion
|
FY22
Q2
|
Oct 18 |
| MWA.US |
Net Sales Rise 14.7% on Record Backlog as Full-Year Sales and Adjusted EBITDA Guidance Raised to 6%–10%
|
FY22
Q1
|
Oct 17 |
| JPM.US |
Managed Revenue Expands 8% to $50.9B as Capital Allocation Shifts from Buybacks to Organic Deployment
|
FY26
Q3
|
Oct 15 |
| UNH.US |
Adjusted EPS Expands 60.6% and Full-Year Outlook Raised to At Least $20.50 on Lower Medical Care Ratio and Optum Turnaround
|
FY26
Q3
|
Oct 15 |